March 17, 2016 / 9:43 PM / a year ago

BRIEF-Health Canada says is conducting review of drug Zydelig

March 17 (Reuters) - Health Canada:

* International clinical trials, including trials in Canada, are being stopped due to serious adverse events with the drug Zydelig, in combination with other cancer drugs

* Health Canada says three additional trials will be amended by implementing added measures to protect participants

* Is also conducting a review of drug Zydelig and will take appropriate next steps as needed

* Four Canadian clinical trials, involving cancer medicine Zydelig (idelalisib) in combination with other cancer medicines, being stopped Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below